Skip to main content
Clinical Trials/NL-OMON45699
NL-OMON45699
Completed
Not Applicable

Intraperitoneal infusion of ex vivo cultured allogeneic Natural Killer cells in recurrent ovarian carcinoma patients. - INTRO

Radboud Universitair Medisch Centrum0 sites10 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Ovarian carcinoma
Sponsor
Radboud Universitair Medisch Centrum
Enrollment
10
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

Trial is onging in other countries

Registry
who.int
Start Date
TBD
End Date
August 28, 2023
Last Updated
2 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patient with a second recurrence of ovarian cancer, based on increasing CA\-125 levels, without symptoms. Patients are included after palliative chemotherapy for their first recurrence. Patients must have a life expectancy of \>6 months and are only enrolled after prior given written informed consent. Patients should be able to undergo a laparoscopy.

Exclusion Criteria

  • Patients with active infections or serious organ failure are excluded. Patients on immunesuppressive drugs and with recent chemotherapy (\<28days ago).

Outcomes

Primary Outcomes

Not specified

Similar Trials